2breathe Technologies Ltd
Digital therapeutic devices to lower high blood pressure, reduce stress and induce sleep
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
2breathe Technologies Ltd | 09/01/2014 | 1-10 |
Our founders, Dr. Benjamin Gavish and his son, Erez Gavish, pioneered the digital therapeutic device field, first in hypertension and now in sleep. The original product, RESPeRATE, is the world’s only FDA-cleared, non-invasive hypertension treatment device. Used by hundreds of thousands of patients and is featured in the American Heart Association statement on non-pharmacological treatments. RESPeRATE only “side effect” was that users were falling asleep as they used it. When 90% of users reported that beyond lowering their blood pressure, it also improved their sleep, we decided to turn the “side effect into a feature” and adapt the technology to help the millions who suffer from sleeplessness. We went back to the drawing board and redesigned the effective device-guided breathing technology into a sleek smartphone powered product.